Search for: "U.S. v. Clark (ronald D.)"
Results 21 - 36
of 36
Sorted by Relevance
|
Sort by Date
31 Dec 2022, 10:34 am
Speakers: Shalanda Baker (Director of the Office of Economic Impact and Diversity and Secretarial Advisor on Equity, U.S. [read post]
16 Feb 2011, 2:16 pm
Rev. 669-690 (2010).Griffin, Ronald C. [read post]
18 Mar 2011, 8:53 am
Biographical details about panelists (listed in alphabetical order): Ronald J. [read post]
25 Jan 2011, 11:05 pm
Craig Callen, Judge John D. [read post]
1 Feb 2019, 10:51 am
21 Lewis & Clark L. [read post]
1 Jun 2012, 7:02 am
Clark, Blue. [read post]
11 Apr 2011, 11:13 am
Clark, John Owen Haley.New Providence, N.J. : LexisNexis, c2010. [read post]
1 Jun 2012, 7:02 am
Clark, Blue. [read post]
2 Oct 2008, 7:43 pm
Gerry of the U.S. [read post]
12 Mar 2012, 8:13 am
So far as books by Justices are concerned, this new offering is more refined, extensive, and current than what had appeared previously in Fenton Martin and Robert Goehlert’s The U.S. [read post]
10 Dec 2013, 6:11 am
Part V then considers the governance implications of the market activities of the NSWF. [read post]
19 Apr 2008, 8:50 am
(Laura Empson of Cass Business School gave a particularly nice presentation on this at lunchtime Thursday, positing that useful ways of thinking about partnership might be as analogous to The Three Musketeers, to Henry V's famous "band of brothers" speech before the Battle of Agincourt, to a buccaneer pirate ship, or, at last, to "Gone With the Wind. [read post]
25 Apr 2011, 5:49 pm
Biographical details about panelists (listed in alphabetical order): Ronald J. [read post]
17 Jun 2019, 2:17 pm
If there is the appearance of a conflict of interest, then we will also withdraw from representation, unless both parties consent to the representation. d. [read post]
12 Aug 2008, 2:00 pm
RE Broker 2 John Brancato U.S. [read post]
13 Apr 2024, 3:33 pm
Prelude to Litigation Phenylpropanolamine (PPA) was a widely used direct α-adrenergic agonist used as a medication to control cold symptoms and to suppress appetite for weight loss.[1] In 1972, an over-the-counter (OTC) Advisory Review Panel considered the safety and efficacy of PPA-containing nasal decongestant medications, leading, in 1976, to a recommendation that the agency label these medications as “generally recognized as safe and effective. [read post]
